Syros Pharmaceuticals, Inc. reports

Location
35 Cambridge Park Drive, Cambridge, MA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
9/19/2024, 01:26 AM
Form type Sec Links Description Filing date Reporting date
8-K Report | Data 8-K Sep 5, 2024 Sep 4, 2024
8-K Report | Data 8-K Aug 12, 2024 Aug 12, 2024
SC 13G/A Report SC 13G/A Aug 2, 2024
10-Q Report | Data 10-Q Jul 31, 2024 Jun 30, 2024
8-K Report | Data FORM 8-K Jun 6, 2024 Jun 5, 2024
10-Q Report | Data 10-Q May 14, 2024 Mar 31, 2024
10-K Report | Data 10-K Mar 27, 2024 Dec 31, 2023
SC 13G Report SC 13G Feb 14, 2024
SC 13G/A Report Feb 13, 2024
SC 13G/A Report SC 13G/A Feb 13, 2024
SC 13G/A Report SC 13G/A Feb 13, 2024
SC 13G/A Report SC 13G/A Feb 9, 2024
SC 13G/A Report SYROS PHARMACEUTICALS, INC. Feb 7, 2024
8-K Report | Data 8-K Jan 8, 2024 Jan 8, 2024
SC 13G Report Jan 2, 2024
SC 13D/A Report SC 13D/A Dec 26, 2023
8-K Report | Data 8-K Dec 19, 2023 Dec 18, 2023
8-K Report | Data 8-K Dec 6, 2023 Dec 6, 2023
10-Q Report | Data 10-Q Nov 14, 2023 Sep 30, 2023
SC 13D Report SC 13D Oct 20, 2023
8-K Report | Data 8-K Oct 2, 2023 Sep 28, 2023
8-K Report | Data 8-K Aug 11, 2023 Aug 9, 2023
10-Q Report | Data 10-Q Aug 8, 2023 Jun 30, 2023
8-K Report | Data 8-K Jul 21, 2023 Jul 18, 2023
8-K Report | Data 8-K Jun 2, 2023 Jun 1, 2023
8-K Report | Data 8-K May 25, 2023 May 25, 2023
10-Q Report | Data 10-Q May 10, 2023 Mar 31, 2023
8-K Report | Data 8-K Mar 10, 2023 Mar 10, 2023
10-K Report | Data 10-K Mar 2, 2023 Dec 31, 2022
SC 13G/A Report Feb 14, 2023
SC 13G/A Report SC 13G/A Feb 14, 2023
SC 13G/A Report SC 13G/A Feb 13, 2023
SC 13G/A Report SC 13G/A Jan 30, 2023
SC 13G Report SYROS PHARMACEUTICALS, INC. Jan 25, 2023
8-K Report | Data 8-K Jan 9, 2023 Jan 9, 2023
8-K/A Report | Data 8-K/A Dec 16, 2022 Sep 15, 2022
8-K Report | Data 8-K Dec 12, 2022 Dec 10, 2022
8-K/A Report | Data 8-K/A Dec 1, 2022 Sep 16, 2022
10-Q Report | Data 10-Q Nov 14, 2022 Sep 30, 2022
SC 13G/A Report Nov 10, 2022
8-K Report | Data 8-K Oct 6, 2022 Oct 3, 2022
SC 13G Report Sep 20, 2022
SC 13G Report Sep 19, 2022
SC 13D/A Report SC 13D/A Sep 16, 2022
8-K Report | Data 8-K Sep 16, 2022 Sep 15, 2022
8-K Report | Data 8-K Sep 15, 2022 Sep 15, 2022
8-K Report | Data 8-K Sep 2, 2022 Sep 2, 2022
10-Q Report | Data SYRS-Q2-2022 Aug 9, 2022 Jun 30, 2022
SC 13D Report SC 13D Jul 13, 2022
SC 13D Report SC 13D Jul 13, 2022
SC 13G Report Jul 8, 2022
8-K Report | Data 8-K Jul 6, 2022 Jul 5, 2022
8-K Report | Data 8-K Jul 5, 2022 Jul 3, 2022
8-K Report | Data 8-K Jun 7, 2022 Jun 1, 2022
10-Q Report | Data 10-Q May 16, 2022 Mar 31, 2022
SC 13G/A Report Apr 11, 2022
10-K Report | Data 10-K Mar 15, 2022 Dec 31, 2021
8-K Report | Data 8-K Mar 8, 2022 Mar 7, 2022
SC 13G/A Report SC 13G/A Feb 14, 2022
SC 13G/A Report SC13G/A Feb 14, 2022
SC 13G/A Report SC 13G/A Feb 11, 2022
SC 13G Report SC 13G Feb 11, 2022
SC 13G/A Report Feb 9, 2022
SC 13G/A Report AMENDMENT NO. 3 Feb 4, 2022
SC 13G/A Report Feb 3, 2022
8-K Report | Data 8-K Jan 10, 2022 Jan 10, 2022
10-Q Report | Data 10-Q Nov 5, 2021 Sep 30, 2021
8-K Report | Data 8-K Oct 13, 2021 Oct 12, 2021
8-K Report | Data 8-K Sep 20, 2021 Sep 20, 2021
8-K Report | Data 8-K Sep 10, 2021 Sep 9, 2021
10-Q Report | Data 10-Q Aug 5, 2021 Jun 30, 2021
8-K Report | Data 8-K Jun 10, 2021 Jun 7, 2021
8-K Report | Data 8-K May 26, 2021 May 26, 2021
10-Q Report | Data 10-Q May 6, 2021 Mar 31, 2021
SC 13G/A Report SC 13G/A Mar 10, 2021
10-K Report | Data 10-K Mar 4, 2021 Dec 31, 2020
8-K Report | Data 8-K Feb 25, 2021 Feb 25, 2021
SC 13G/A Report SC 13G/A Feb 16, 2021
SC 13G/A Report SCHEDULE 13G (AMENDMENT #1) Feb 16, 2021
SC 13G/A Report SC 13G/A Feb 11, 2021
SC 13G/A Report Feb 8, 2021
SC 13G/A Report AMENDMENT NO. 2 Feb 5, 2021
SC 13G/A Report ARCH VENTURE FUND VII, L.P. - SYROS PHARMACEUTICALS -- SCH 13G/A (#4E) Feb 2, 2021
SC 13G/A Report Feb 1, 2021
8-K Report | Data 8-K Jan 20, 2021 Jan 19, 2021
8-K Report | Data 8-K Jan 19, 2021 Jan 19, 2021
8-K Report | Data 8-K Jan 11, 2021 Jan 8, 2021
8-K Report | Data 8-K Dec 23, 2020 Dec 23, 2020
SC 13G Report SC 13G Dec 18, 2020
SC 13G Report SC 13G Dec 14, 2020
8-K Report | Data 8-K Dec 8, 2020 Dec 8, 2020
8-K Report | Data 8-K Dec 7, 2020 Dec 4, 2020
10-Q Report | Data 10-Q Nov 5, 2020 Sep 30, 2020
8-K Report | Data 8-K Oct 26, 2020 Oct 24, 2020
SC 13G/A Report SC 13G/A Oct 9, 2020
8-K Report | Data 8-K Sep 9, 2020 Sep 8, 2020
10-Q Report | Data 10-Q Aug 6, 2020 Jun 30, 2020
8-K Report 8-K Jun 12, 2020 Jun 11, 2020
10-Q Report | Data 10-Q May 7, 2020 Mar 31, 2020
SC 13G Report SCHEDULE 13G Apr 2, 2020
10-K Report | Data 10-K Mar 5, 2020 Dec 31, 2019
SC 13G/A Report SC 13G/A Feb 14, 2020
SC 13G/A Report ARCH VENTURE FUND VII, L.P. - SYROS PHARMACEUTICALS, INC. -- SCHEDULE 13G/A(#3) Feb 13, 2020
8-K Report 8-K Feb 13, 2020 Feb 12, 2020
SC 13G/A Report SC 13G/A Feb 12, 2020
SC 13G/A Report FORM SC 13G/A Feb 12, 2020
SC 13G/A Report Feb 7, 2020
SC 13G Report Feb 7, 2020
8-K Report 8-K Jan 13, 2020 Jan 12, 2020
8-K Report 8-K Dec 20, 2019 Dec 19, 2019
8-K Report 8-K Dec 18, 2019 Dec 17, 2019
8-K Report 8-K Dec 2, 2019 Dec 2, 2019
10-Q Report | Data 10-Q Nov 12, 2019 Sep 30, 2019
8-K Report 8-K Nov 4, 2019 Nov 1, 2019
8-K Report 8-K Oct 25, 2019 Oct 24, 2019
8-K Report 8-K Oct 24, 2019 Oct 24, 2019
8-K Report 8-K Oct 17, 2019 Oct 17, 2019
SC 13G Report Sep 9, 2019
SC 13G Report SC 13G Sep 6, 2019
10-Q Report | Data 10-Q Aug 1, 2019 Jun 30, 2019
8-K Report 8-K Jun 12, 2019 Jun 11, 2019
SC 13G/A Report May 10, 2019
10-Q Report | Data 10-Q May 1, 2019 Mar 31, 2019
8-K Report 8-K Apr 24, 2019 Apr 24, 2019
SC 13G Report Apr 9, 2019
8-K Report 8-K Apr 8, 2019 Apr 5, 2019
10-K Report | Data 10-K Mar 7, 2019 Dec 31, 2018
SC 13G/A Report ARCH VENTURE FUND VII, L.P. - SYROS PHARMACEUTICALS, INC. -- SCHEDULE 13G/A(#2) Feb 14, 2019
SC 13G Report SC 13G Feb 14, 2019
SC 13D/A Report SC 13D/A Feb 14, 2019
SC 13G/A Report Feb 13, 2019
SC 13G Report Feb 8, 2019
8-K Report 8-K Jan 11, 2019 Jan 8, 2019
8-K Report 8-K Jan 7, 2019 Jan 6, 2019
8-K Report 8-K Dec 3, 2018 Dec 2, 2018
8-K Report 8-K Nov 15, 2018 Nov 15, 2018
10-Q Report | Data 10-Q Nov 1, 2018 Sep 30, 2018
8-K Report 8-K Sep 26, 2018 Sep 26, 2018
10-Q/A Report 10-Q/A Aug 24, 2018 Jun 30, 2018
10-Q/A Report 10-Q/A Aug 24, 2018 Mar 31, 2018
10-K/A Report 10-K/A Aug 24, 2018 Dec 31, 2017
10-Q Report | Data 10-Q Aug 7, 2018 Jun 30, 2018
8-K Report 8-K Jun 15, 2018 Jun 11, 2018
10-Q Report | Data 10-Q May 10, 2018 Mar 31, 2018
8-K Report 8-K Mar 15, 2018 Mar 12, 2018
10-K Report | Data 10-K Mar 12, 2018 Dec 31, 2017
8-K Report 8-K Mar 12, 2018 Mar 7, 2018
SC 13G/A Report Feb 14, 2018
SC 13G/A Report Feb 13, 2018
SC 13G/A Report ARCH VII - SYROS PHARMACEUTICALS 13GA(#1) Feb 2, 2018
8-K Report 8-K Feb 2, 2018 Feb 2, 2018
8-K Report 8-K Jan 31, 2018 Jan 30, 2018
8-K Report 8-K Jan 31, 2018 Jan 31, 2018
8-K Report 8-K Jan 30, 2018 Jan 30, 2018
8-K Report 8-K Jan 12, 2018 Jan 12, 2018
8-K Report 8-K Jan 8, 2018 Jan 8, 2018
8-K Report 8-K Dec 11, 2017 Dec 10, 2017
10-Q Report | Data 10-Q Nov 8, 2017 Sep 30, 2017
8-K Report 8-K Oct 6, 2017 Oct 6, 2017
8-K Report 8-K Sep 29, 2017 Sep 28, 2017
SC 13D/A Report SC 13D/A Aug 21, 2017
10-Q Report | Data 10-Q Aug 9, 2017 Jun 30, 2017
8-K Report 8-K Jun 12, 2017 Jun 8, 2017
10-Q Report | Data 10-Q May 15, 2017 Mar 31, 2017
8-K Report 8-K Apr 26, 2017 Apr 26, 2017
8-K Report 8-K Apr 21, 2017 Apr 20, 2017
10-K Report | Data 10-K Mar 20, 2017 Dec 31, 2016
SC 13G/A Report Feb 14, 2017
SC 13G/A Report Feb 14, 2017
SC 13G/A Report SYROS PHARMACEUTICALS, INC. -- SCHEDULE 13G/A (AMEND. #1) Feb 13, 2017
8-K Report 8-K Jan 30, 2017 Jan 27, 2017
8-K Report 8-K Jan 9, 2017 Jan 9, 2017
10-Q Report | Data 10-Q Nov 14, 2016 Sep 30, 2016
10-Q Report | Data 10-Q Aug 15, 2016 Jun 30, 2016
8-K Report 8-K Aug 15, 2016 Aug 15, 2016
SC 13D Report SC 13D Jul 14, 2016
SC 13D Report SC 13D Jul 11, 2016
SC 13G Report Jul 11, 2016
8-K Report 8-K Jul 6, 2016 Jul 6, 2016
SC 13G Report Jul 6, 2016